🆕💥large cohort in VA
People who have recovered from #COVID19 have a greater risk of kidney disease, even if they only experienced mild to moderate covid-19 symptoms and not hospitalized
Post-acute COVID-19 care should involve attention to kidney disease.
https://t.co/q7X1z4ykYz
Updated Shorter Is Better tables: fantastic new JAMA male cUTI RCT by @Ddrekonja and colleagues! Not only important for short course, but either TMP-SMX or FQs used; 7 d TMP-SMX works for cUTI!
Also included the single dose azithro for atypical CAP study @wfwrighID found.
COVID STEROID 2 trial
🆕💥💥preprint
Among patients with #COVID19 and severe hypoxia, dexamethasone 12 mg did NOT result in statistically significant more days alive without life support at 28 days than dexamethasone 6 mg
Awaiting for #Recoverytrial
https://t.co/xFwKXlHLmk
@JGPharmD Have gotten many hosp staff where number 1 is a sticking point for them when they come to talk with us about benefit/risks... at the end I like to show them the attached article from 2 years ago discussing mRNAs past and future...seems to help many.
https://t.co/EAN99LrLbW
🔥Breaking news🔥
Press Release
Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with #COVID19 in @NIAIDNews Sponsored ACTT-2 Trial
One-day reduction in median recovery TIME 😯 https://t.co/gq91Lxow6I
Breaking news 🔥🔥🔥
The most anticipated study
Finally Published COVID-19 PEP RCT "821 asymptomatic participants " @NEJM@boulware_dr Hydroxychloroquine did NOT prevent #COVID19 infection when uded as postexposure prophylaxis within 4 days after exposure
https://t.co/d1WVEmPDDq
FDA Requires Stronger Warning About Risk of Neuropsychiatric Events Associated with Asthma and Allergy Medication Singulair and Generic Montelukast https://t.co/wnSHlqBvSq
NEW🔥⚡ Multi-center retrospective cohort study in #AAC
Clinical success was similar between patients receiving CZA & (MVB)for treatment of CRE infections, despite ceftazidime/avibactam being used more often as combination therapy. #IDTwitter
https://t.co/ln3cb5s2iJ
Just in time for Mardi Gras 🥳 Pharmacists answer the burning question, should alcohol be avoided while taking antibiotics💊? New evidence review in AAC at https://t.co/AtAd6nAsu3. Keep handy for your next dinner party!
Is Piperacillin-Tazobactam Effective for the Treatment of Pyelonephritis Caused by Extended-Spectrum β-Lactamase–Producing Organisms? https://t.co/XJ0MqTMIop
NEW🔥 @BesuTeshome@ICHEJournal
showed the associated⬆️ in risk of new resistance emergence with⬆️ duration of anti-PSA BL Abx exposure in the critically ill does not appear to exhibit a “ceiling effect” as the cumulative duration of exposure⬆️ #IDTwitter
https://t.co/2RoEHoWQjf